PREVIEW: No return to growth for GSK in Q1
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline will present its Q1 2013 results on 24 April, with analysts estimating that the UK pharma will report a drop in growth of 5% for the quarter ending 31 March. GSK concedes that there were a number of events in Q1 2012 and during the course of last year that will impact the comparison for Q1 2013.